• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL FLEXNAV DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL FLEXNAV DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Catalog Number FNAV-DS-LG
Device Problems Difficult to Insert (1316); Material Deformation (2976)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/29/2023
Event Type  malfunction  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that on (b)(6) 2023, a 27mm navitor valve was chosen for implant, using a large flexnav delivery system.During deployment of the valve, the patient¿s blood pressure was observed to drop.Subsequently, the system was removed from the anatomy.Reinsertion was attempted after flushing the blood from all flush ports as much as possible, but it was difficult to insert due to a split of the tip of the valve capsule.The patient had a mild tortuous anatomy.As adhesion of the thrombus was recognized when the bioprosthetic valve was removed, the system was changed including valve and delivery system.During advancement of flexnav, the physician attempted to deliver the device while pushing the non-abbott guidewire excessively.A strong resistance was felt when passing through the aortic arch.It was suspected that the apex was perforated at that time.Pericardial effusion was observed, requiring pericardiocentesis.This has led to cardiac tamponade.This was attributed to the guidewire.After the pericardial drainage was performed, the chest was opened, then arrest hemorrhage.Shifted to surgical aortic valve replacement (avr).The patient is reported to be still on percutaneous cardiopulmonary support (pcps) as of (b)(6) 2023.This has reportedly caused a clinically significant delay.
 
Manufacturer Narrative
An event of difficult insertion and material deformation was reported.Information from the field indicated that reinsertion was difficult due to a flared valve capsule tip.Based on available information, the reported difficult insertion appears to be related to the flared valve capsule tip.However, a root cause for the flared valve capsule tip could not be conclusively determined.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLEXNAV DELIVERY SYSTEM
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG#3007113487
177 county road b east
st. paul MN 55117 1789
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18366815
MDR Text Key331361056
Report Number2135147-2023-05612
Device Sequence Number1
Product Code NPT
UDI-Device Identifier05415067031389
UDI-Public05415067031389
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P190023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/08/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberFNAV-DS-LG
Device Lot Number8942148
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/29/2023
Initial Date FDA Received12/20/2023
Supplement Dates Manufacturer Received12/21/2023
Supplement Dates FDA Received01/08/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/14/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age86 YR
Patient SexMale
Patient Weight49 KG
-
-